Study Data Show INTUNIV (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom …
Study Data Show INTUNIV (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom …
Shire plc , the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV⢠Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder , at a major psychiatric meeting.  The primary objective of this study was to evaluate the efficacy of INTUNIV, dosed either in the morning or evening …
Read more on PR Newswire via Yahoo! Finance
More Meth Drug Addiction Info:
- NZD/USD Classical 05.21 – Yahoo Finance
- NZD/USD Classical 05.20 – Yahoo Finance
- US Dollar Forecast Remains Bullish Amidst Large S&P 500 Declines …
- Attention Deficit Hyperactivity Disorder (ADHD) – Drug Pipeline …
- MutualFirst Financial, Inc. Declares Cash Dividend – Yahoo Finance …
- Osiris Beats on Lower Expenses – Yahoo Finance (Www.OSIRonline.com …
- Kislak Re-enters Mortgage Marketplace with Dual Offering – PR …
- Treatment For Attention Deficit Disorder : Information on Anxiety …
- In Yahoo! Finance Stock screener, how can I put% values, for …
- NZD/USD Classical 05.21 – Yahoo Finance | Forex Account Managers